Zentalis Pharmaceuticals, Inc.

Healthcare

NASDAQ:ZNTL · NASDAQ Global Market

Market Cap $266.95M Beta 1.97 P/E (TTM) -2.1

$3.75 +6.53%

+$0.23 today

52W Low $1.13High $6.95

Vol 0.89M · Avg 1.98M

EPS (TTM)-$1.77

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+179.85%

Period High

$6.61

Period Low

$1.16

Latest

$3.75

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Immix Biopharma, Inc.

NASDAQ:IMMX

$459.70M

Sutro Biopharma, Inc.

NASDAQ:STRO

$278.70M

MacroGenics, Inc.

NASDAQ:MGNX

$251.71M

Shattuck Labs, Inc.

NASDAQ:STTK

$236.64M

ALX Oncology Holdings Inc.

NASDAQ:ALXO

$212.61M

Artiva Biotherapeutics, Inc.

NASDAQ:ARTV

$211.08M

Whitehawk Therapeutics Inc

NASDAQ:WHWK

$205.72M

Precision BioSciences, Inc.

NASDAQ:DTIL

$78.25M

Pliant Therapeutics, Inc.

NASDAQ:PLRX

$69.97M

Instil Bio, Inc.

NASDAQ:TIL

$53.71M

What is the latest ZNTL filing?

The latest filing shown is 8-K dated May 27, 2026.

How many recent filings does ZNTL have?

Intrinsic Alpha currently shows 20 recent filings for ZNTL.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.